<DOC>
	<DOCNO>NCT00384293</DOCNO>
	<brief_summary>This 105-week clinical study patient heterozygous familial hypercholesterolemia intensive Low Density Lipoprotein-cholesterol ( LDL-C ) lower therapy intend assess affect MK0524A carotid intima medium thicken use ultrasound compare patient take placebo . There 12 schedule clinic visit involve review medical history , physical exam , vital sign , laboratory testing , ultrasound imaging , electrocardiogram .</brief_summary>
	<brief_title>Carotid IMT ( Intima Media Thickening ) Study ( 0524A-041 ) ( TERMINATED )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Patients 18 70 year age Heterozygous Familial Hypercholesterolemia LDLC great equal 100mg/dL triglyceride less equal 400mg/dL Visit 1 stable dose intensive LDLC lower therapy A condition , opinion investigator , might pose risk patient interfere participate study Patients le 80 % drug study compliance Patients chronic medical condition know influence serum lipid lipoproteins significantly affect ultrasound acoustic window Patients unstable dose medication Pregnant lactate woman , woman intend become pregnant exclude Patient diabetes mellitus poorly control , take new recently adjust antidiabetic pharmacotherapy ( exception +/ 10 unit insulin ) Patients follow condition : high grade stenosis ( great 75 % ) carotid artery , chronic heart failure , uncontrolled/unstable cardiac arrhythmia , unstable hypertension , active chronic hepatobiliary hepatic disease , HIV positive , episode gout ( within 1 year )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>